跳至主要内容
临床试验/TCTR20161007004
TCTR20161007004招募中4 期

The Retinal Pigment Epithelial Detachment changes in Aged-related macular degeneration treated with Aflibercept, Ranibizumab and Bevacizumab

Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 60 人开始时间: 2016年10月7日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1.Newly diagnosed wet AMD patient confirmed by FFA or OCT and diagnosed by retina specialist in 2010 to 2017
  • 2.Presence of PED at the time of diagnosis
  • 3.No history of previous macular laser treatment or photodynamic therapy
  • 4.No concurrent other macular diseases in the study eye
  • Obtained OCT scanning from SPECTRALIS SD-OCT

排除标准

  • 1.Poor quality of OCT image at baseline and at 12th month visit
  • 2.Lost follow up before 6th month visit
  • 3.Presence of RPE rip after initial Anti VEGF treatment

研究者

发起方
Faculty of Medicine, Chulalongkorn University

相似试验

The Retinal Pigment Epithelial Detachment changes in... | 临床试验